                         SEQUENCE LISTING

<110>  Altermune Limited
 
<120>  NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF

<130>  AVV-C-P2065PCT

<150>  1517859.3
<151>  2015-10-08

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  42
<212>  RNA
<213>  Artificial

<220>
<223>  Synthetic Aptamer

<400>  1
gggauuuaau cgccguagaa aagcauguca aagccggaac cc                          42


<210>  2
<211>  48
<212>  RNA
<213>  Artificial

<220>
<223>  Synthetic Aptamer

<400>  2
ggacggauuu aaucgccgua gaaaagcaug ucaaagccgg aaccgucc                    48


<210>  3
<211>  42
<212>  RNA
<213>  Artificial

<220>
<223>  Synthetic Aptamer

<400>  3
gggauuuaau cgccguagaa aagcauguca aagccggaac cc                          42


<210>  4
<211>  118
<212>  PRT
<213>  Human

<400>  4

Glu Val Lys Leu Asp Glu Thr Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Met Lys Leu Ser Cys Val Ala Ser Gly Phe Ile Phe Ser Asp Tyr 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ser Pro Glu Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Ala Gln Ile Arg Thr Asn Pro Tyr Asn Tyr Glu Thr Tyr Tyr Ser Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Ser Ser 
65                  70                  75                  80  


Val Tyr Leu Gln Met Lys Asn Leu Arg Ser Glu Asp Met Gly Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Trp Ser His Tyr Ala Leu Asp Asn Trp Gly Gln Gly Thr 
            100                 105                 110         


Ser Val Thr Val Ser Ser 
        115             


<210>  5
<211>  112
<212>  PRT
<213>  Human

<400>  5

Asp Val Leu Val Thr Gln Asn Pro Leu Ser Leu Ser Val Ser Leu Gly 
1               5                   10                  15      


Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Asn Leu Val His Asn 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Leu Leu Ile His Arg Ile Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Phe Cys Ser Gln Ser 
                85                  90                  95      


Thr His Ile Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


